Hedge Fund - Casdin Capital
Alnylam Pharmaceuticals Inc. (ALNY)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q2 (2024-06-30) | $41,310,000 | 3.16% | 170,000 | $157.87 |
| 2 | 2024 - Q1 (2024-03-31) | $53,503,100 | 3.97% | 358,000 | $166.82 |
| 3 | 2023 - Q4 (2023-12-31) | $37,324,950 | 3.66% | 195,000 | $170.34 |
| 4 | 2023 - Q3 (2023-09-30) | $35,420,000 | 3.92% | 200,000 | $191.12 |
| 5 | 2023 - Q2 (2023-06-30) | $53,183,200 | 4.64% | 280,000 | $198.26 |
| 6 | 2023 - Q1 (2023-03-31) | $54,086,400 | 4.45% | 270,000 | $210.20 |
| 7 | 2022 - Q4 (2022-12-31) | $86,742,250 | 6.72% | 365,000 | $213.29 |
| 8 | 2022 - Q3 (2022-09-30) | $129,704,000 | 8.52% | 648,000 | $190.74 |
| 9 | 2022 - Q2 (2022-06-30) | $117,409,000 | 9.92% | 805,000 | $141.87 |
| 10 | 2022 - Q1 (2022-03-31) | $163,290,000 | 7.32% | 1,000,000 | $152.35 |
| 11 | 2021 - Q4 (2021-12-31) | $169,580,000 | 4.77% | 1,000,000 | $185.86 |
| 12 | 2021 - Q3 (2021-09-30) | $188,810,000 | 4.69% | 1,000,000 | $187.58 |
| 13 | 2021 - Q2 (2021-06-30) | $169,520,000 | 4.3% | 1,000,000 | $146.46 |
| 14 | 2021 - Q1 (2021-03-31) | $124,247,000 | 3.7% | 880,000 | $150.49 |
| 15 | 2020 - Q4 (2020-12-31) | $101,377,000 | 3% | 780,000 | $133.53 |
| 16 | 2020 - Q3 (2020-09-30) | $90,272,000 | 4.04% | 620,000 | $142.11 |
| 17 | 2020 - Q2 (2020-06-30) | $81,461,000 | 4.82% | 550,000 | $134.81 |
| 18 | 2020 - Q1 (2020-03-31) | $63,677,000 | 6.75% | 585,000 | $115.43 |
| 19 | 2019 - Q4 (2019-12-31) | $59,313,000 | 5.45% | 515,000 | $99.70 |
| 20 | 2019 - Q3 (2019-09-30) | $48,252,000,000 | 4.99% | 600,000 | $79.11 |
| 21 | 2019 - Q2 (2019-06-30) | $47,164,000,000 | 4.41% | 650,000 | $76.72 |
| 22 | 2019 - Q1 (2019-03-31) | $41,585,000 | 4.56% | 445,000 | $83.64 |
| 23 | 2018 - Q4 (2018-12-31) | $25,883,000 | 4.42% | 355,000 | $76.92 |
| 24 | 2018 - Q3 (2018-09-30) | $23,630,000 | 2.87% | 270,000 | $100.59 |
| 25 | 2018 - Q2 (2018-06-30) | $26,592,000 | 3.71% | 270,000 | $99.19 |
| 26 | 2018 - Q1 (2018-03-31) | $29,775,000 | 5.23% | 250,000 | $128.92 |
| 27 | 2017 - Q4 (2017-12-31) | $25,410,000 | 6.18% | 200,000 | $125.65 |
| 28 | 2017 - Q3 (2017-09-30) | $23,498,000 | 6.63% | 200,000 | $85.36 |
| 29 | 2017 - Q2 (2017-06-30) | $8,375,000 | 3.09% | 105,000 | $63.91 |
| 30 | 2017 - Q1 (2017-03-31) | $2,819,000 | 1.66% | 55,000 | $46.22 |
| 31 | 2016 - Q4 (2016-12-31) | $3,182,000 | 2.62% | 85,000 | $41.87 |
| 32 | 2016 - Q3 (2016-09-30) | $2,643,000 | 2.14% | 39,000 | $70.55 |
| 33 | 2016 - Q2 (2016-06-30) | $4,023,000 | 4% | 72,500 | $63.00 |
| 34 | 2016 - Q1 (2016-03-31) | $5,649,000 | 6.48% | 90,000 | $66.49 |
| 35 | 2015 - Q4 (2015-12-31) | $5,648,000 | 4.99% | 60,000 | $92.72 |
The displayed share prices are average quarterly stock market prices.